Redirecting Immune, Lipid and Metabolic Drivers of Early Cardiovascular Disease: The RESET Cohort Study

Recruiting now

Conditions studied: Cardiovascular Diseases, Metabolic Syndrome, Non-Alcoholic Fatty Liver Disease

In brief

Project RESET is a Singapore National Medical Research Council Large Collaborative Grant funded program that brings together a nationwide community of cardiovascular, metabolic, and digital health researchers, as well as clinicians across primary and tertiary care to study the immune, lipid and metabolic drivers of early cardiovascular disease. RESET incorporates a nested randomised controlled trials (RCT) to test the use of a combined digital wearable and AI-human symbiotic lifestyle intervention to halt or reverse the progression of early disease.

Key facts

Study ID

NCT06211868

Run by

National University Hospital, Singapore

People needed

3000

Starts

2024-03-01

Expected to finish

2030-09-01

Last updated by the study team

2024-10-15

Who can join

Age: 40 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 40-70 years old
• ASCVD (atherosclerotic cardiovascular disease) score of 5% and higher

You may not qualify if…

• Previous major cardiovascular disease (myocardial infarction, heart failure, ischemic stroke)
• Limited life expectancy
• Other ongoing unstable medical conditions
• Pregnant women

Where it is running

• NUS — Singapore, Singapore (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.